ElixMD: Check Your Semaglutide Eligibility Online
Licensed providers review your intake within 24–48 hours. No waiting room, no prior authorization, no insurance required. Start with a simple health intake today.
Check My Eligibility at ElixMD →- You likely qualify with a BMI of 30+ — no other conditions required.
- You may qualify with a BMI of 27–29.9 if you have one weight-related health condition.
- Qualifying conditions include type 2 diabetes, high blood pressure, high cholesterol, PCOS, and sleep apnea.
- Diabetes is not required — most women taking semaglutide for weight loss do not have diabetes.
- Certain contraindications (thyroid history, pancreatitis, pregnancy) will disqualify you — these are reviewed during intake.
The Core Eligibility Criteria for Semaglutide
Semaglutide for weight loss (sold as Wegovy, or prescribed as compounded semaglutide through telehealth programs) follows the same eligibility framework established in clinical trials and FDA approval guidelines. Providers — whether in a clinic or online — use these same standards.
BMI of 30 or Higher
If your BMI is 30 or above, you meet the primary clinical threshold for semaglutide eligibility. No additional health conditions are required. This classification — clinical obesity — is the clearest path to approval in most telehealth programs.
- BMI is calculated from your height and weight — your provider will confirm this during intake
- No specific medical history is required beyond this threshold
- Most programs approve candidates at BMI 30+ within 24–48 hours of intake
- You do not need a prior weight loss attempt on record for telehealth programs (though some insurance plans do require this)
BMI of 27–29.9 with a Weight-Related Health Condition
If your BMI falls between 27 and 29.9 — classified as overweight rather than obese — you can still qualify for semaglutide if you have at least one of the following weight-related health conditions:
- Type 2 diabetes — the original indication for semaglutide (Ozempic); also qualifies for weight loss use
- Hypertension (high blood pressure) — one of the most common qualifying conditions
- Dyslipidemia (high cholesterol or triglycerides) — cardiovascular risk factor that qualifies independently
- PCOS (polycystic ovary syndrome) — particularly relevant for women; often accompanied by insulin resistance that GLP-1 directly addresses
- Obstructive sleep apnea — a recognized obesity-related condition that qualifies at the 27+ BMI threshold
- Cardiovascular disease — established heart disease qualifies independently
- Prediabetes — an increasingly recognized qualifying condition in many programs
Semaglutide for weight loss is not currently indicated for BMIs below 27. If your BMI is under this threshold, most licensed providers will not prescribe it for weight loss purposes regardless of other factors. This is a clinical guideline, not a judgment about your goals.
Who Cannot Take Semaglutide — The Contraindications
Eligibility isn't only about meeting the BMI threshold — it also means you don't have conditions that make semaglutide medically inadvisable. These contraindications are reviewed during every clinical intake and are non-negotiable.
Conditions That Rule Out Semaglutide Entirely
- Personal or family history of medullary thyroid carcinoma (MTC) — semaglutide carries a warning for thyroid C-cell tumors; this history is an absolute contraindication
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — a genetic condition associated with MTC risk; disqualifies from semaglutide regardless of BMI
- Current pregnancy — semaglutide is not approved for use during pregnancy and should be discontinued before attempting conception
- Breastfeeding — safety during lactation has not been established; most providers will not prescribe during this period
- Hypersensitivity to semaglutide — known allergic reaction to semaglutide or any component of the formulation
Conditions That Require Careful Provider Review
These don't automatically disqualify you, but they require careful evaluation by your provider before prescribing:
- History of pancreatitis — GLP-1 medications have been associated with pancreatic inflammation; active or recent pancreatitis warrants extreme caution
- Diabetic retinopathy — rapid improvement in blood sugar control can temporarily worsen retinopathy; requires ophthalmologist monitoring
- Severe kidney disease — dose adjustment or alternative may be needed
- Severe gastrointestinal disease — including gastroparesis; GLP-1 medications slow gastric emptying, which can worsen these conditions
- Current use of insulin or insulin secretagogues — combination increases hypoglycemia risk; requires dose adjustment and careful monitoring
This list is not exhaustive. Your full medication list, health history, and family history are all reviewed during intake. Never self-assess contraindications — that determination belongs to your provider, who has your complete clinical picture.
Special Situations — Eligibility Questions Women Most Often Ask
Beyond the standard criteria, several common situations come up repeatedly when women are assessing their eligibility. Here's what the evidence and clinical practice say about each.
| Situation | Eligible? | What to Know |
|---|---|---|
| I have PCOS | Usually yes | PCOS is a qualifying condition at BMI 27+. GLP-1 also directly addresses insulin resistance common in PCOS |
| I don't have diabetes | Yes | Diabetes is not required. Wegovy is specifically approved for weight loss in non-diabetic adults |
| I'm perimenopausal or menopausal | Yes | No restrictions by menopausal status. Providers may consider hormonal context when reviewing your overall plan |
| I'm over 65 | Usually yes | No upper age limit. Providers review overall health status and medications more carefully for older adults |
| I have a thyroid condition (not MTC) | Case by case | Hypothyroidism or hyperthyroidism does not automatically disqualify you — MTC history does. Provider review required |
| I'm on antidepressants | Usually yes | Most antidepressants don't interact directly with semaglutide. Your full medication list is reviewed during intake |
| I've tried other weight loss medications before | Yes | Prior weight loss medication use does not disqualify you. Providers may note what you've tried previously |
| I'm planning to get pregnant | Discuss with provider | Most providers recommend discontinuing semaglutide at least 2 months before attempting conception |
What the Eligibility Review Actually Looks Like
Understanding the criteria is one thing — knowing what the actual process involves helps you prepare. Here's what a standard telehealth eligibility review covers.
-
01
Height and weight — to calculate BMI and confirm you meet the primary threshold
-
02
Weight-related health conditions — to establish a qualifying condition if BMI is 27–29.9
-
03
Personal and family medical history — specifically thyroid cancer history, pancreatitis, and other contraindications
-
04
Current medications — to screen for interactions, particularly with insulin and diabetes medications
-
05
Lab work — some programs require recent bloodwork (metabolic panel, HbA1c, thyroid) before prescribing; others order it for you
-
06
Pregnancy and breastfeeding status — confirmed before prescribing; semaglutide is not prescribed during either
Does Insurance Affect Who Is Eligible?
This is where many women get confused — and the answer matters.
Clinical eligibility (the medical criteria above) is the same whether you're using insurance or paying out of pocket. The difference is that insurance companies often add their own additional hurdles on top of clinical criteria — things like documented prior weight loss attempts, specific lab values, or physician referrals — before they'll approve coverage.
Why Out-of-Pocket Telehealth Is Often Faster
- No prior authorization required — the single biggest time barrier with insurance is eliminated entirely
- No step therapy requirement — insurers often require you to fail other treatments first; self-pay programs skip this
- No appeal process — insurance denials can take weeks to appeal; self-pay programs approve or decline based on clinical criteria only
- Faster start — most telehealth programs go from intake to prescription in 24–72 hours; insurance approval can take weeks
- Same clinical standards — licensed providers use the same eligibility criteria regardless of payment method
"The clinical threshold for semaglutide eligibility hasn't changed. What's changed is how quickly and privately women can access a real evaluation — without needing a referral, a waiting list, or an insurance approval."
— HauteFlair Women's Health Editorial Team
What This Means for You
If you've been wondering whether you qualify, the fastest and most accurate answer comes from a licensed provider reviewing your actual health information — not from self-assessing against a checklist online.
The criteria are clear, consistently applied, and based entirely on your health profile — not your insurance status, your primary care doctor's schedule, or how long you've been trying to lose weight. If your BMI is 30+, you very likely qualify. If your BMI is 27–29.9 and you have any of the qualifying conditions listed above, you likely qualify as well.
The most productive next step is simply starting the intake process. It takes about 10 minutes, costs nothing upfront at most programs, and gives you a real clinical answer within 24–48 hours.
Frequently Asked Questions
What BMI do you need to qualify for semaglutide?
Can I get semaglutide if I don't have diabetes?
Who cannot take semaglutide?
Can I get semaglutide if I have PCOS?
Does age affect semaglutide eligibility?
How do I find out if I'm eligible for semaglutide?
Can I take semaglutide if I'm on other medications?
Is semaglutide safe for women over 40?
Results vary. Semaglutide requires a prescription and medical evaluation. Eligibility is determined by a licensed provider based on your individual health profile — not by this article. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed medical professional before starting any prescription medication. ElixMD is an independent telehealth service; HauteFlair is not responsible for medical outcomes. This article contains affiliate links to ElixMD.
